Censo Biotechnologies Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Censo Biotechnologies Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11167
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Censo Biotechnologies Ltd (Censo) formerly Roslin Cellab Limited, a subsidiary of Roslin Foundation, is a provider of human cells and contract research services for drug discovery, toxicity testing and cell banking. The company offers iPSC services; differentiated cell types; in vitro assays; and custom cell culture services. It also provides training and consultancy services. Censo utilizes stem cell technology to discover and develop new treatments for diseases. The company’s expertise spans in cell printing, 2D cell culture, matrices and 3D culture systems, media and supplement development, cryopreservation technologies and bioreactors among others. Censo is headquartered in Midlothian, Scotland, the UK.

Censo Biotechnologies Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Censo Biotechnologies Raises USD1.7 Million in Financing 10
Partnerships 11
Censo Biotech Partners with University of Leeds 11
Evotec Enters into Agreement with Censo Biotech 12
Cellectricon Enters into Agreement with Censo Biotech 13
Reinnervate Enters Into Co-Development Agreement With Roslin Cellab 14
Reinnervate Enters Into Co-Development Agreement With Roslin Cellab 15
Acquisition 16
Roslin Cellab Acquires Roslin Cell Sciences 16
Censo Biotechnologies Ltd – Key Competitors 17
Censo Biotechnologies Ltd – Key Employees 18
Censo Biotechnologies Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Government and Public Interest 20
Apr 17, 2018: Censo Biotechnologies: Update on iPSC-derived Cortical Neuronal High Content Assay 20
Nov 21, 2017: Censo Biotechnology awarded SMART funding to develop new stem cell technology 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Censo Biotechnologies Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Censo Biotechnologies Raises USD1.7 Million in Financing 10
Censo Biotech Partners with University of Leeds 11
Evotec Enters into Agreement with Censo Biotech 12
Cellectricon Enters into Agreement with Censo Biotech 13
Reinnervate Enters Into Co-Development Agreement With Roslin Cellab 14
Reinnervate Enters Into Co-Development Agreement With Roslin Cellab 15
Roslin Cellab Acquires Roslin Cell Sciences 16
Censo Biotechnologies Ltd, Key Competitors 17
Censo Biotechnologies Ltd, Key Employees 18
Censo Biotechnologies Ltd, Subsidiaries 19

List of Figures
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Censo Biotechnologies Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Energy Future Holdings Corp.-エネルギー分野:企業M&A・提携分析
    Summary Energy Future Holdings Corp. (EFH Corp) is an electric utility company. It manages a portfolio of competitive and regulated energy companies serving the Texas electricity market. The company’s competitive businesses consist of Luminant, which is involved in power generation and related minin …
  • Statkraft AS:企業のM&A・事業提携・投資動向
    Statkraft AS - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Statkraft AS Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Taageer Finance Co (TFCI):企業の財務・戦略的SWOT分析
    Taageer Finance Co (TFCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mediacom Communications Corp:企業の戦略的SWOT分析
    Mediacom Communications Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Elisa Oyj (ELISA):企業の財務・戦略的SWOT分析
    Elisa Oyj (ELISA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PanAust Ltd:企業の戦略・SWOT・財務情報
    PanAust Ltd - Strategy, SWOT and Corporate Finance Report Summary PanAust Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Damodar Valley Corporation:発電所・企業SWOT分析
    Damodar Valley Corporation – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Yingli Green Energy Holding Company Limited (YGE):企業の財務・戦略的SWOT分析
    Yingli Green Energy Holding Company Limited (YGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Groupe Sodiaal:企業の戦略・SWOT・財務情報
    Groupe Sodiaal - Strategy, SWOT and Corporate Finance Report Summary Groupe Sodiaal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Globus Medical Inc (GMED):企業の財務・戦略的SWOT分析
    Globus Medical Inc (GMED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Allegiance Capital Corporation:企業の戦略・SWOT・財務情報
    Allegiance Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary Allegiance Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • ICF International, Inc.:戦略・SWOT・企業財務分析
    ICF International, Inc. - Strategy, SWOT and Corporate Finance Report Summary ICF International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Laboratory Corp of America Holdings (LH):医療機器:M&Aディール及び事業提携情報
    Summary Laboratory Corp of America Holdings (LabCorp) is a provider of clinical laboratory services and end-to-end drug development support. It focuses on the development and commercialization of a wide range of diagnostic technologies and testing services. The company offers clinical diagnostics la …
  • IHI Aerospace Co Ltd:企業の戦略・SWOT・財務情報
    IHI Aerospace Co Ltd - Strategy, SWOT and Corporate Finance Report Summary IHI Aerospace Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ProteinSimple-医療機器分野:企業M&A・提携分析
    Summary ProteinSimple, formerly Cell Biosciences Inc, a subsidiary of Bio Techne Corp, is a medical device company that offers protein analysis solutions. The company offers products such as simple plex systems, simple western systems, micro-flow imaging systems, cIEF and CE-SDS; gel documentation s …
  • GEN energija, d.o.o.:企業の戦略的SWOT分析
    GEN energija, d.o.o. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • BerGenBio ASA (BGBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary BerGenBio ASA (BerGenBio) is a clinical-stage biopharmaceutical company that develops drugs to treat multiple aggressive cancers. The company develops epithelial-mesenchymal transition inhibitors for acquired cancer drug-resistance and metastasis. Its BGB324 is an AXL kinase inhibitor which …
  • Allergy Therapeutics Plc (AGY):製薬・医療:M&Aディール及び事業提携情報
    Summary Allergy Therapeutics Plc (Allergy Therapeutics) is a specialty pharmaceutical company that develops therapies for allergy treatment and allergy prevention. The company offers a wide range of aluminium-free allergy vaccines and diagnostics. It uses Micro Crystalline Tyrosine (MCT) as an alter …
  • THIMM Group GmbH + Co. KG:企業の戦略・SWOT・財務情報
    THIMM Group GmbH + Co. KG - Strategy, SWOT and Corporate Finance Report Summary THIMM Group GmbH + Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Reliance Industries Ltd (RELIANCE):企業の財務・戦略的SWOT分析
    Reliance Industries Ltd (RELIANCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆